Ayurvedic perspective on non-alcoholic fatty liver disease and its management

Introduction

Ayurveda is one of the oldest holistic medical systems, originating in India over 5,000 years ago and emphasizing the maintenance of health through harmony between individual constitution and natural environment. It focuses on prevention and restoration of physiological balance through diet, lifestyle, and therapeutic interventions.

In the modern era, rapid urbanization, sedentary behavior, and dietary excess have contributed to a marked rise in lifestyle disorders, including obesity, type 2 diabetes mellitus, dyslipidemia, and non-alcoholic fatty liver disease (NAFLD). These conditions are broadly comparable to Santarpanajanya Vyadhi in Ayurveda, primarily driven by Kapha and Meda Dhatu vitiation.

NAFLD is a progressive metabolic liver disorder characterized by hepatic fat accumulation ranging from simple steatosis to steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Its increasing prevalence is strongly associated with obesity, insulin resistance, and metabolic syndrome, with limited definitive pharmacological treatment options.

Ayurvedic perspective and etiopathogenesis

Nidana (causative factors):

Ayurveda describes NAFLD-related pathology under Beejadushti, Aharaja, Viharaja, and Manasika Nidana, corresponding to genetic, dietary, lifestyle, and psychological factors.

Beejadushti (genetic factors):

Genetic predisposition leads to structural and functional abnormalities of metabolic tissues, contributing to altered lipid handling and increased susceptibility to Meda accumulation, analogous to modern genetic polymorphisms influencing NAFLD progression.

Aharaja hetu (dietary factors):

Excess intake of Guru, Snigdha, Madhura, and Abhishyandi foods, along with incompatible diets, leads to Agnimandya and Ama formation. This promotes Meda Dhatu accumulation and hepatic lipid deposition.

Viharaja hetu (lifestyle factors):

Sedentary behavior, daytime sleep, and reduced physical activity impair metabolic efficiency and contribute to Kapha aggravation and weight gain.

Manasika hetu (psychological factors):

Stress, anxiety, anger, and disturbed sleep impair digestion and metabolism through Agni suppression, leading to systemic metabolic imbalance.

Modern etiological correlates

• Genetic factors:

NAFLD is associated with multiple gene variants affecting lipid metabolism, insulin resistance, oxidative stress, inflammation, and fibrosis (e.g., PNPLA3, TM6SF2, TLR4, TNF, IL6).

• Dietary and lifestyle factors:

High-fat diets, refined carbohydrates, sedentary behavior, smoking, and alcohol-independent metabolic overload contribute to hepatic steatosis and insulin resistance.

• Metabolic syndrome and diabetes:

NAFLD strongly correlates with metabolic syndrome, characterized by dyslipidemia, hypertension, hyperglycemia, and central obesity, with risk increasing as metabolic abnormalities accumulate.

• Associated clinical conditions:

Polycystic ovarian syndrome (PCOS) and obstructive sleep apnea (OSA) further increase insulin resistance and systemic inflammation, accelerating NAFLD progression.

• Samprapti (pathogenesis):

Nidana sevana → Agnimandya → Ama formation → Srotorodha → Meda Dhatu vitiation → abnormal lipid deposition in Yakrit → hepatic dysfunction (Yakritmeda) → clinical manifestations such as fatigue, indigestion, hepatomegaly, and metabolic imbalance.

Clinical features

NAFLD is often asymptomatic in early stages. Common features include fatigue, abdominal heaviness, malaise, hepatomegaly, and metabolic disturbances, with many patients being overweight or obese.

Management approach

• Conventional management:

Lifestyle modification remains the cornerstone of treatment, including weight reduction, dietary control, and physical activity. Pharmacotherapy is limited and includes agents such as insulin sensitizers and antioxidants with variable efficacy.

• Ayurvedic management:

• Nidana parivarjana:

Avoidance of Kapha–Meda aggravating factors such as heavy, oily foods, sedentary behavior, daytime sleep, and incompatible diet forms the primary intervention.

• Shodhana chikitsa: Detoxification therapies are indicated in selected cases:

1. Virechana for Pitta–Kapha elimination and hepatic cleansing
2. Vamana for Kapha reduction and metabolic activation
3. Raktamokshana in specific inflammatory conditions

• Shamana chikitsa:

Herbs with Tikta, Kashaya rasa and Deepana–Pachana properties such as Guduchi, Katuki, Bhumi amalaki, Pippali, and Haritaki support hepatic metabolism and reduce fat accumulation.

• Rasayana chikitsa:

Rejuvenative agents like Triphala, Guggulu, Shilajatu, and Bhallataka improve antioxidant status, tissue regeneration, and metabolic resilience.

• Yoga and physical activity:

Regular exercise and yogic practices such as Surya Namaskara, Pranayama, and selected asanas improve insulin sensitivity, reduce weight, and normalize metabolic function.

Lifestyle modification:

Regular exercise, dietary discipline, fasting where appropriate, and avoidance of sedentary habits are essential for long-term disease control.

• Pathya and Apathya Pathya Ahara:

Conclusion

NAFLD represents a multifactorial metabolic disorder with strong overlap with Ayurvedic Santarpanajanya Vyadhi. Integrative management combining dietary regulation, Panchakarma, herbal therapy, yoga, and lifestyle modification offers a comprehensive approach to disease prevention and progression control. However, further high-quality clinical studies are required to validate and standardize Ayurvedic interventions in NAFLD management.¹

References:

1. Panjeta N. NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS MANAGEMENT- A CRITICAL REVIEW. wjpmr, 2025, 11(6), 4-11. https://www.wjpmr.com/download/article/135052025/1748685146.pdf